| Source: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Type: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Risk: by definition reduces risk of disease or cancer. Down Target direction of risk indicates lower cancer risk. ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.
Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral
|
| 1700- | Se, | Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers |
| - | Review, | Var, | NA |
| 1698- | Se, | Association between Dietary Zinc and Selenium Intake, Oxidative Stress-Related Gene Polymorphism, and Colorectal Cancer Risk in Chinese Population - A Case-Control Study |
| - | Human, | CRC, | NA |
| 4485- | Se, | Selenium stimulates the antitumour immunity: Insights to future research |
| - | Review, | NA, | NA |
| 4486- | Se, | Chit, | Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis |
| - | in-vitro, | Liver, | HepG2 |
| 4492- | Se, | Selenium in cancer prevention: a review of the evidence and mechanism of action |
| - | Review, | Var, | NA |
| 4495- | Se, | Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort |
| - | Study, | CRC, | NA |
| 4496- | Se, | Selenium status and survival from colorectal cancer in the European prospective investigation of cancer and nutrition |
| - | Analysis, | CRC, | NA |
| 4724- | Se, | Chapter Four - Selenium in the Redox Regulation of the Nrf2 and the Wnt Pathway |
| - | Review, | Var, | NA |
| 4744- | Se, | Chemo, | antiOx, | Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing? |
| - | Review, | Pca, | NA |
| 4711- | Se, | Association of selenium status and blood glutathione concentrations in blacks and whites |
| - | Human, | Nor, | NA |
| 4714- | Se, | SSE, | SeNPs, | Selenium in cancer management: exploring the therapeutic potential |
| - | Review, | Var, | NA |
| 4722- | Se, | The Yin and Yang of Nrf2-Regulated Selenoproteins in Carcinogenesis |
| - | Review, | Var, | NA |
| 4745- | SeNPs, | Chemo, | Translational Selenium Nanoparticles Promotes Clinical Non-small-cell Lung Cancer Chemotherapy via Activating Selenoprotein-driven Immune Manipulation |
| - | Study, | NSCLC, | NA |
| 4609- | SeNPs, | Physiological Benefits of Novel Selenium Delivery via Nanoparticles |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Diabetic, | NA |
| 4603- | SeNPs, | Therapeutic applications of selenium nanoparticles |
| - | Review, | Var, | NA |
| 4491- | SeNPs, | Chit, | VitC, | Synthesis of a Bioactive Composition of Chitosan–Selenium Nanoparticles |
| - | Study, | NA, | NA |
| - | in-vitro, | Pca, | NA |
| 1429- | SFN, | Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast |
| - | in-vivo, | Nor, | NA | - | Human, | Nor, | NA |
| 4136- | Silicon, | Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4133- | Silicon, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
| - | Study, | AD, | NA |
| 5802- | Sper, | Spermidine reduces cancer-related mortality in humans |
| - | Review, | Var, | NA |
| 1706- | SSE, | Selenium in Prostate Cancer: Prevention, Progression, and Treatment |
| - | Review, | Pca, | NA |
| 1697- | SSE, | Calc, | Calcium intake may explain the reduction of colorectal cancer odds by dietary selenium - a case-control study in Poland |
| - | Human, | CRC, | NA |
| 1688- | SSE, | Potential Role of Selenium in the Treatment of Cancer and Viral Infections |
| - | Review, | Var, | NA |
| 4739- | SSE, | Chemo, | Rad, | Therapeutic Benefits of Selenium in Hematological Malignancies |
| - | Review, | Var, | NA |
| 4742- | SSE, | Antitumor Effects of Selenium |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Sepsis, | NA |
| 4741- | SSE, | Selenium in Oncological Intervention |
| - | Review, | Var, | NA |
| 4740- | SSE, | Optimising Selenium for Modulation of Cancer Treatments |
| - | Review, | Var, | NA |
| 4753- | SSE, | Chemo, | Selenium and Lung Cancer: A Systematic Review and Meta Analysis |
| - | Review, | Lung, | NA |
| 5082- | SSE, | Rationale for the treatment of cancer with sodium selenite |
| - | Review, | Var, | NA |
| 4500- | SSE, | Dietary selenium affects host selenoproteome expression by influencing the gut microbiota |
| - | in-vivo, | Nor, | NA |
| 4498- | SSE, | Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | IBD, | NA |
| 4497- | SSE, | Selenium and inflammatory bowel disease |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| 4494- | SSE, | Advances in the study of selenium and human intestinal bacteria |
| - | Review, | IBD, | NA | - | Review, | Var, | NA |
| 4614- | SSE, | Rad, | Updates on clinical studies of selenium supplementation in radiotherapy |
| - | Review, | Nor, | NA |
| 3965- | Taur, | Taurine-Related Nutritional Knowledge Has a Positive Effect on Intake of Taurine and Cognitive Function in the Elderly |
| - | Human, | AD, | NA |
| 3963- | Taur, | Past Taurine Intake Has a Positive Effect on Present Cognitive Function in the Elderly |
| - | Human, | AD, | NA |
| 4869- | Uro, | Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 4864- | Uro, | Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease |
| - | Review, | AD, | NA |
| 4876- | Uro, | Urolithin A in Health and Diseases: Prospects for Parkinson’s Disease Management |
| - | Review, | Park, | NA | - | Review, | AD, | NA |
| 4314- | VitB1/Thiamine, | Unraveling the molecular mechanisms of vitamin deficiency in Alzheimer's disease pathophysiology |
| - | Review, | AD, | NA |
| 4327- | VitB1/Thiamine, | Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease |
| - | Study, | AD, | NA |
| 4056- | VitB12, | VitB6, | FA, | Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis |
| - | Review, | AD, | NA |
| 4324- | VitB5, | Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
| - | Study, | AD, | NA | - | Study, | Park, | NA |
| 4326- | VitB5, | Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease |
| - | in-vivo, | HD, | NA |
| 4325- | VitB5, | Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain |
| - | Study, | AD, | NA | - | Study, | Park, | NA |
| 4323- | VitB5, | Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease |
| - | Study, | AD, | NA |
| 4052- | VitB6, | B-Vitamin Intake and Biomarker Status in Relation to Cognitive Decline in Healthy Older Adults in a 4-Year Follow-Up Study |
| - | Study, | AD, | NA |
| 4055- | VitB6, | VitD3, | Vitamin B6 and vitamin D deficiency co-occurrence in geriatric memory patients |
| - | Study, | AD, | NA |
| 4057- | VitB6, | VitB12, | FA, | Folate, Vitamin B6 and Vitamin B12 Intake and Mild Cognitive Impairment and Probable Dementia in the Women’s Health Initiative Memory Study |
| - | Study, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:785 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid